- Associated Press•3 years ago
Dutch chemicals maker Royal DSM NV has struck a deal to buy Canada's Patheon Inc. for $195 million (145 million euros), combine it with its own drug manufacturing operations, and spin them off into a new ...
- Thomson Reuters ONE•3 years agoRoyal DSM and JLL create leading pharma services company in USD 2.6 bn transaction; Global CDMO company combines DSM Pharmaceutical Products and Patheon
JLL Partners ("JLL"), a leading middle-market private equity firm, and Royal DSM, the global Life Sciences and Materials Sciences company, today announced the creation of a new company, which ...
We're sorry this is all we were able to find about this topic.
Toronto - Toronto Delayed Price. Currency in CAD
At close: 3:59 PM EDT
|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||10.33 - 10.36|
|52wk Range||10.33 - 10.36|
|1y Target Est||N/A|
|P/E Ratio (ttm)||N/A|
|Avg Vol (3m)||N/A|
|Dividend & Yield||N/A (N/A)|